Log in to MyACC
Advancing the Cardiovascular Care of the Oncology Patient (In Person)
Join us in person in Washington, DC for Advancing the Cardiovascular Care of the Oncology Patient taking place Feb. 9 – 11. This is an interdisciplinary and interspecialty course to provide clinicians and researchers with the tools needed to improve the cardiovascular (CV) health of cancer patients in your everyday practice.
Cancer remains the second leading cause of death in the United States, exceeded only by heart disease, with an estimated 1.9 million new cases in 2022. Cancer treatment can have a diverse array of long-term and late effects, including CV events such as heart failure, valvular disease, coronary artery disease, arrhythmia, peripheral arterial disease, and thromboembolic events. In this contemporary treatment era, cardiologists, oncologists, and the entire interprofessional team need to understand the different types of cancers and cancer therapies (e.g., cytotoxic chemotherapy, radiation therapy, transplantation, targeted and immune therapies) and their associated cardiovascular risks, to help mitigate the associated cardiovascular complications.
Register today to join leading experts and course chairs Ana Barac, MD, PhD, FACC and Bonnie Ky, MD, MSCE, FACC in person at the Heart House in Washington, DC Feb. 9 – 11 as they share emerging strategies and best practices to manage the health of cancer patients. This educational experience is designed for you to stay on the leading edge of this rapidly evolving field!
Can't join us in person? Join us virtually to get all the education you need to stay at the leading edge of this rapidly evolving field!
Goal
The goal of this course is to equip the global cardio-oncology community with actionable knowledge and science to advance patient-centered, evidence-based, collaborative cardiovascular and cancer care for our patients living with and beyond cancer.
Target Audience
This educational activity is intended to address the educational needs for cardiologists, oncologists, internists, pharmacists, nurses, trainees, and all members of the interprofessional care team who advance the clinical care of, and conduct clinical research that is relevant to, the growing population of cancer patients and survivors at risk for, or suffer from, cardiovascular disease.
Themes
Innovative, evidence-based, actionable, current, multi-disciplinary, patient-centered
Learning Objectives
- Understand the oncologic indications, mechanisms of action, and cardiotoxicity risk of specific therapies that comprise the pillars of cancer treatment (chemotherapy, immune therapy, targeted therapy, and radiation).
- Define the evidence supporting clinical, imaging and biomarker-guideline recommendations regarding risk stratification and monitoring strategies in cancer patients treated with potentially cardiotoxic therapies.
- Apply evidence-based pharmacologic and non-pharmacologic strategies to mitigate and actively manage the short- and long-term cardiotoxicity risk in patients living with and beyond cancer.
- Recognize the mechanistic and epidemiologic overlap between cancer and cardiovascular disease, independent of the cardiotoxicity of cancer therapies.
- Describe the impact of health disparities, genomic ancestry, and social determinants of health in cardiovascular disease in patients living with and beyond cancer.
- Describe the pathophysiologic basis of amyloidosis, as well as current and emerging diagnostic and treatment strategies.
- Design a multi-disciplinary, interprofessional cardio-oncology care team and successful framework to advance the overall cardiovascular care of cancer patients and survivors.
Course Chairs
Ana Barac, MD, PhD, FACC
Inova Health System
Bonnie Ky, MD, MSCE, FACC
University of Pennsylvania, Perelman School of Medicine
Course Vice Chair
Richard Cheng, MD, FACC
University of Washington
Planning Committee
Alana Ferrari, PharmD
University of Virginia Medical Center
Teresa López-Fernández, MD
La Paz University Hospital
Vivek Narayan, MD, MS
Hospital of the University of Pennsylvania
Alexi Vasbender, PhD, RN
University of Michigan
Eric Yang, MD, FACC
University of California
- Online: Click the Register button at the top of the page
- Phone: 800-253-4636 or 202-375-6000
Registration for Advancing the Cardiovascular Care of the Oncology Patient includes breakfast, lunch, refreshment breaks, and course materials.
| In-Person Registration Rates | Early Bird Until Oct. 31 |
Advanced Nov. 1 to Jan. 10 |
Regular After Jan. 10 |
| Physician Member | $799 | $949 | $999 |
| Physician Non-Member | $999 | $1,149 | $1,299 |
| Reduced (FIT, CVT, Emeritus) | $549 | $699 | $799 |
Cancellations
Cancellation, substitution, or transfer to another course is allowed if written notification is received four weeks before a scheduled course. A full refund minus a $250 processing fee will be given for written notifications received fewer than four weeks before the first day of the course. No refund will be given for no-shows.
ACC reserves the right to cancel the course in the unlikely event of insufficient enrollment or other unforeseen circumstances. If a course is canceled or postponed, ACC will refund registration tuition but cannot be held responsible for other costs or expenses, including cancellation/change penalties assessed by airlines, travel agencies or hotels.
Clinical Topics: Cardio-Oncology
Keywords:
